LACK OF CONCOMITANT DRUG EFFECT

LACK OF CONCOMITANT DRUG EFFECT was reported 57 times

These drug classes are most commonly taken by patients reporting LACK OF CONCOMITANT DRUG EFFECT:

# Drug Count
0 GLP-1 Receptor Agonist [EPC] 15
1 Corticosteroid [EPC] 14
2 Benzodiazepine [EPC] 10
3 Aminosalicylate [EPC] 8
4 Opioid Agonist [EPC] 8
5 Serotonin-3 Receptor Antagonist [EPC] 8
6 Anti-epileptic Agent [EPC] 6
7 alpha-Adrenergic Blocker [EPC] 5
8 beta3-Adrenergic Agonist [EPC] 5
9 Tumor Necrosis Factor Blocker [EPC] 4
10 Kinase Inhibitor [EPC] 3
11 Orexin Receptor Antagonist [EPC] 3
12 Phosphodiesterase 5 Inhibitor [EPC] 3
13 Androgen [EPC] 2
14 Fluoroquinolone Antibacterial [EPC] 2
15 Janus Kinase Inhibitor [EPC] 2
16 Acetylcholine Release Inhibitor [EPC] 1
17 Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] 1
18 Alkylating Drug [EPC] 1
19 Central alpha-2 Adrenergic Agonist [EPC] 1
20 Dietary Cholesterol Absorption Inhibitor [EPC] 1
21 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1
22 Expectorant [EPC] 1
23 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 1
24 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
25 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
26 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
27 Histamine-1 Receptor Antagonist [EPC] 1
28 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1
29 Insulin Analog [EPC] 1
30 Mood Stabilizer [EPC] 1
31 Neuromuscular Blocker [EPC] 1
32 Nonergot Dopamine Agonist [EPC] 1
33 Nonsteroidal Anti-inflammatory Drug [EPC] 1
34 Nucleoside Metabolic Inhibitor [EPC] 1
35 Proton Pump Inhibitor [EPC] 1
36 Pyruvate Kinase Activator [EPC] 1
37 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 1
38 Sulfonamide Antimicrobial [EPC] 1
39 Thiazide Diuretic [EPC] 1